Form 8-K - Current report:
SEC Accession No. 0001140361-24-045855
Filing Date
2024-11-08
Accepted
2024-11-08 16:20:47
Documents
13
Period of Report
2024-11-08
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K ef20038285_8k.htm   iXBRL 8-K 32668
  Complete submission text file 0001140361-24-045855.txt   171592

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imcr-20241108.xsd EX-101.SCH 3991
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20241108_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20241108_pre.xml EX-101.PRE 16050
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20038285_8k_htm.xml XML 4442
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 241440924
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)